Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Cancer Cell
|
September 2, 2022
ctDNA-guided adjuvant chemotherapy for colorectal cancer-ready for prime time?
Claus L Andersen, Ellen Heitzer
Epigenomics
|
November 4, 2016
Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer
Iben Lyskjær, Mads H Rasmussen, Claus L Andersen
Bioinformatics (Oxford, England)
|
March 27, 2007
SNPTools: a software tool for visualization and analysis of microarray data
Frank J Sørensen, Claus L Andersen, Carsten Wiuf
Clinical Epigenetics
|
January 29, 2021
MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples
Trine B Mattesen, Claus L Andersen, Jesper B Bramsen
Annals of Surgical Oncology
|
April 19, 2026
ASO Author Reflections: Potential of Circulating Tumor DNA in Stratifying Patients with Localized pMMR Colon Cancer to Neoadjuvant Therapy
Henry G Smith, Tenna V Henriksen, Claus L Andersen
Bioinformatics (Oxford, England)
|
December 8, 2010
Rseg--an R package to optimize segmentation of SNP array data
Philippe Lamy, Carsten Wiuf, Torben F Ørntoft, et al.
Nucleic Acids Research
|
August 11, 2006
Genotyping and annotation of Affymetrix SNP arrays
Philippe Lamy, Claus L Andersen, Friedrik P Wikman, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
|
August 30, 2002
Active, but not inactive, human centromeres display topoisomerase II activity in vivo
Claus L Andersen, Annelise Wandall, Eigil Kjeldsen, et al.
BMC Bioinformatics
|
November 13, 2007
A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays
Philippe Lamy, Claus L Andersen, Lars Dyrskjot, et al.
BMC Cancer
|
October 31, 2015
Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study
Mai-Britt W Ørntoft, Hans J Nielsen, Torben F Ørntoft, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Cancer Cell
|
September 2, 2022
ctDNA-guided adjuvant chemotherapy for colorectal cancer-ready for prime time?
Claus L Andersen, Ellen Heitzer
Epigenomics
|
November 4, 2016
Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer
Iben Lyskjær, Mads H Rasmussen, Claus L Andersen
Bioinformatics (Oxford, England)
|
March 27, 2007
SNPTools: a software tool for visualization and analysis of microarray data
Frank J Sørensen, Claus L Andersen, Carsten Wiuf
Clinical Epigenetics
|
January 29, 2021
MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples
Trine B Mattesen, Claus L Andersen, Jesper B Bramsen
Annals of Surgical Oncology
|
April 19, 2026
ASO Author Reflections: Potential of Circulating Tumor DNA in Stratifying Patients with Localized pMMR Colon Cancer to Neoadjuvant Therapy
Henry G Smith, Tenna V Henriksen, Claus L Andersen
Bioinformatics (Oxford, England)
|
December 8, 2010
Rseg--an R package to optimize segmentation of SNP array data
Philippe Lamy, Carsten Wiuf, Torben F Ørntoft, et al.
Nucleic Acids Research
|
August 11, 2006
Genotyping and annotation of Affymetrix SNP arrays
Philippe Lamy, Claus L Andersen, Friedrik P Wikman, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
|
August 30, 2002
Active, but not inactive, human centromeres display topoisomerase II activity in vivo
Claus L Andersen, Annelise Wandall, Eigil Kjeldsen, et al.
BMC Bioinformatics
|
November 13, 2007
A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays
Philippe Lamy, Claus L Andersen, Lars Dyrskjot, et al.
BMC Cancer
|
October 31, 2015
Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study
Mai-Britt W Ørntoft, Hans J Nielsen, Torben F Ørntoft, et al.
Page
of 7